Journal of affective disorders Journal

Overview
Identity
View All

publication venue for

A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: Target engagement and rationale for the development in mental disorders.. 321-327. 2024
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase®).. 922-927. 2024
Association between rumination, suicidal ideation and suicide attempts in persons with depressive and other mood disorders and healthy controls: A systematic review and meta-analysis.. 513-527. 2024
Electroencephalography (EEG) spectral signatures of selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs) and vortioxetine in major depressive disorder: A systematic review.. 798-819. 2024
Trajectories of maternal parenting stress and adolescent behavioral symptoms in unmarried families: The role of family immigration status.. 297-306. 2024
Association between cognitive functioning, suicidal ideation and suicide attempts in major depressive disorder, bipolar disorder, schizophrenia and related disorders: A systematic review and meta-analysis.. 381-399. 2024
A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse exists.. 589-594. 2024
Preclinical and clinical efficacy of kappa opioid receptor antagonists for depression: A systematic review.. 816-827. 2024
Comparing suicide completion rates in bipolar I versus bipolar II disorder: A systematic review and meta-analysis.. 480-488. 2024
The role of KCNQ channel activators in management of major depressive disorder.. 364-372. 2024
National trends and correlates of treatment resistance in major depressive episode and associated suicidal ideation and behaviors among adults in the United States.. 342-349. 2024
Effects of anhedonia on health-related quality of life and functional outcomes in major depressive disorder: A systematic review and meta-analysis.. 684-698. 2024
Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis.. 753-762. 2024
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.. 342-354. 2024
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data.. 314-322. 2023
Is psychiatric diagnostic remission associated with reduced prevalence of moderate to severe pain interference and improved functioning among adults with lifetime psychiatric disorders?. 585-591. 2023
Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder.. 893-898. 2023
Association between decreased interhemispheric functional connectivity of the insula and duration of illness in recurrent depression.. 88-95. 2023
Biomarkers of ketamine's antidepressant effect: An umbrella review.. 598-606. 2022
Association of current and remitted bipolar disorders with health-related quality of life: Findings from a nationally representative sample in the US.. 33-40. 2022
Long-term depressive symptoms and midlife brain age.. 436-441. 2022
Trends in major depressive episodes and mental health treatment among older adults in the United States, 2010-2019.. 299-303. 2022
Impact of Tai Chi as an adjunct treatment on brain connectivity in geriatric depression.. 1-6. 2022
Why are women more likely to attempt suicide than men? Analysis of lifetime suicide attempts among US adults in a nationally representative sample.. 157-164. 2022
Increased prefrontal cortex connectivity associated with depression vulnerability and relapse.. 133-141. 2022
Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: A systematic review and meta-analysis.. 449-461. 2021
Mechanisms of change in depression and anxiety within a mind-body activity intervention for chronic pain.. 534-541. 2021
The intersection of implementation science and community-based suicide prevention research: Opportunities to advance the field.. 237-239. 2021
Recovery from past suicide attempts: Correlates of time since the last attempt in a national sample of US adults.. 98-105. 2020
Stages of major depressive disorder and behavioral multi-morbidities: Findings from nationally representative epidemiologic study.. 443-452. 2020
Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: A retrospective chart review.. 660-666. 2020
Network structures and temporal stability of self- and informant-rated affective symptoms in Alzheimer's disease.. 1084-1092. 2020
Longer-term open-label study of adjunctive riluzole in treatment-resistant depression.. 102-108. 2019
Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders.. 450-457. 2019
Inaccuracy between subjective reports and objective measures of sleep duration and clinical correlates in bipolar disorder.. 226-230. 2019
The impact of prolonged exposure therapy on social support and PTSD symptoms.. 410-417. 2019
Use of mental health services by community-resident adults with DSM-IV anxiety and mood disorders in a violence-prone area: São Paulo, Brazil.. 145-152. 2019
Familial and social transmission of suicidal behavior in older adults.. 589-596. 2018
GWAS and systems biology analysis of depressive symptoms among smokers from the COPDGene cohort.. 16-22. 2018
12-month prevalence and concomitants of DSM-IV depression and anxiety disorders in two violence-prone cities in Brazil.. 204-211. 2018
12-month trajectories of depressive symptoms among nurses-Contribution of personality, job characteristics, coping, and burnout.. 67-73. 2018
Severity of anxiety- but not depression- is associated with oxidative stress in Major Depressive Disorder.. 193-200. 2017
Therapeutic relationship in the treatment of geriatric depression with executive dysfunction.. 130-137. 2017
Exploring the excess mortality due to depressive symptoms in a community-based sample: The role of Alzheimer's Disease.. 163-70. 2016
The association of an inability to form and maintain close relationships due to a medical condition with anxiety and depressive disorders.. 130-6. 2016
Mood disorder symptoms and elevated cardiovascular disease risk in patients with bipolar disorder.. 138:405-8. 2012
Under-treatment of depression in older persons.. 136:789-96. 2011